Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire
validation of a french version of FACT-GOG/NTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO.
Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms
DRUG: Paclitaxel|DRUG: EPO
Validation of a french version of FACT-GOG/NTX of peripheral neurotoxicity questionnaire
- incidence and severity of the peripheral neurotoxicity according to whether the patients are treated or not by EPO|- variation of the rate of haemoglobin during chemotherapy|- Incidence of the thrombo-embolic events according to whether the patients are treated or not by EPO
validation of a french version of FACT-GOG/NTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO.